Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -1.68%6.12B | 2.10%4.07B | 2.19%1.84B | -2.76%8.34B | -1.25%6.23B | -1.78%3.99B | 2.29%1.8B | 12.66%8.58B | 14.33%6.31B | 18.77%4.06B |
| Refunds of taxes and levies | 14.24%330.04M | 19.15%225.03M | 53.59%120.01M | 1.73%373.9M | 4.09%288.9M | 0.86%188.87M | -7.83%78.14M | -27.72%367.56M | -30.56%277.55M | -44.04%187.25M |
| Cash received relating to other operating activities | -4.53%51.55M | 8.29%36.5M | 63.92%22.87M | 6.82%73.39M | -1.86%54M | -24.30%33.7M | -50.59%13.96M | 42.31%68.71M | 12.39%55.02M | 26.39%44.52M |
| Cash inflows from operating activities | -1.00%6.51B | 2.92%4.33B | 4.76%1.99B | -2.50%8.79B | -1.03%6.57B | -1.90%4.21B | 1.04%1.9B | 10.33%9.02B | 11.30%6.64B | 13.29%4.29B |
| Goods services cash paid | 2.99%4.79B | 7.32%3.18B | 11.22%1.65B | 8.11%6.24B | 9.33%4.65B | 11.33%2.96B | 1.59%1.48B | 8.62%5.77B | 5.25%4.25B | 1.25%2.66B |
| Staff behalf paid | 6.98%524.06M | 8.08%350.98M | 5.08%170.79M | 6.60%684.54M | 4.25%489.87M | 5.01%324.73M | 9.21%162.54M | 10.38%642.18M | 12.16%469.91M | 13.26%309.23M |
| All taxes paid | -1.02%380.21M | 0.97%251.87M | -23.31%113.41M | 0.44%495.2M | 3.82%384.14M | 8.44%249.45M | 26.68%147.88M | 24.53%493.02M | 18.83%370.01M | 16.95%230.03M |
| Cash paid relating to other operating activities | -2.98%277.25M | -5.66%181.86M | -15.29%84.39M | 23.22%384.28M | 20.68%285.77M | 43.32%192.78M | 34.86%99.62M | -21.01%311.87M | -17.59%236.8M | -29.81%134.51M |
| Cash outflows from operating activities | 2.77%5.97B | 6.29%3.97B | 6.60%2.02B | 8.10%7.8B | 9.01%5.81B | 11.83%3.73B | 5.21%1.89B | 7.96%7.22B | 5.36%5.33B | 1.38%3.34B |
| Net cash flows from operating activities | -29.60%538.74M | -23.43%365.72M | -1,817.85%-32.76M | -45.08%987.73M | -41.73%765.29M | -49.93%477.63M | -97.50%1.91M | 20.95%1.8B | 44.31%1.31B | 92.32%954.01M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -72.46%392.39M | -93.44%92.18M | -98.73%15M | -67.53%1.43B | -65.84%1.43B | -47.75%1.41B | 124.76%1.18B | 1,588.08%4.39B | 20,755.00%4.17B | --2.69B |
| Cash received from returns on investments | -89.63%13.3M | -91.18%11.22M | -99.32%693K | -71.36%128.24M | -69.79%128.24M | -57.99%127.18M | 130.60%102.03M | 592.65%447.79M | 1,431.30%424.45M | 1,652.41%302.76M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 20,191.78%2.09M | 28,011.39%2.08M | ---- | --10.3K | --10.3K | --7.4K | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | -73.75%407.78M | -93.12%105.48M | -98.78%15.69M | -67.89%1.55B | -66.20%1.55B | -48.79%1.53B | 125.22%1.28B | 1,389.67%4.84B | 9,522.36%4.6B | 17,178.33%2.99B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -81.00%49.23M | -84.51%32.54M | -76.60%17.52M | 193.54%315.06M | 222.82%259.11M | 518.59%210.07M | 231.61%74.87M | 35.74%107.33M | 29.74%80.26M | 5.97%33.96M |
| Cash paid to acquire investments | -77.30%330M | -76.99%330M | -75.39%300M | -78.34%1.45B | -76.51%1.45B | -67.53%1.43B | 108.38%1.22B | 1,077.93%6.71B | 30,845.00%6.19B | --4.42B |
| Cash outflows from investing activities | -77.86%379.23M | -77.95%362.54M | -75.46%317.52M | -74.07%1.77B | -72.67%1.71B | -63.06%1.64B | 112.96%1.29B | 950.97%6.82B | 7,557.88%6.27B | 13,788.95%4.45B |
| Net cash flows from investing activities | 117.86%28.55M | -129.76%-257.06M | -2,448.38%-301.83M | 89.13%-215.81M | 90.45%-159.86M | 92.33%-111.88M | 69.10%-11.84M | -511.85%-1.98B | -4,807.28%-1.67B | -9,805.18%-1.46B |
| Financing cash flow | ||||||||||
| Cash from borrowing | -31.49%932.61M | -48.66%350.8M | -99.91%222.76K | -1.21%1.57B | -14.15%1.36B | -31.51%683.35M | -59.71%245.19M | 11.44%1.59B | 22.44%1.59B | 99.49%997.8M |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --426.85K | ---- |
| Cash inflows from financing activities | -31.49%932.61M | -48.66%350.8M | -99.91%222.76K | -1.21%1.57B | -14.17%1.36B | -31.51%683.35M | -59.71%245.19M | 11.44%1.59B | 22.47%1.59B | 99.49%997.8M |
| Borrowing repayment | -4.37%1.35B | -12.31%600.82M | -55.01%150.24M | -15.15%1.47B | -18.08%1.41B | -31.34%685.2M | -36.28%333.98M | 23.54%1.73B | 64.77%1.72B | 99.53%998.03M |
| Dividend interest payment | -21.16%447.04M | -26.59%16.14M | -36.48%8.21M | 115.76%575.5M | 117.02%567M | 5.98%21.99M | 24.36%12.93M | 25.00%266.73M | 26.66%261.27M | 43.70%20.75M |
| Cash payments relating to other financing activities | -58.95%4.87M | -59.94%2.7M | -87.82%644.15K | 64.54%21.92M | 454.62%11.86M | 255.74%6.75M | 281.15%5.29M | -16.32%13.32M | 6.69%2.14M | 303.05%1.9M |
| Cash outflows from financing activities | -9.48%1.8B | -13.20%619.67M | -54.83%159.1M | 2.75%2.07B | 0.21%1.99B | -30.05%713.94M | -34.28%352.2M | 23.34%2.01B | 58.40%1.99B | 98.15%1.02B |
| Net cash flows from financing activities | -38.21%-868.07M | -778.94%-268.87M | -48.47%-158.88M | -17.57%-498.4M | -57.39%-628.09M | -33.72%-30.59M | -247.42%-107.01M | -105.41%-423.92M | -1,053.25%-399.06M | -53.34%-22.88M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -44.55%11.08M | -22.39%12.42M | 131.17%6.95M | 1.59%26.32M | 1.33%19.98M | -28.76%16M | 138.19%3.01M | -52.05%25.91M | -68.28%19.72M | -36.61%22.46M |
| Net increase in cash and cash equivalents | -10,716.20%-289.7M | -142.09%-147.79M | -326.99%-486.52M | 151.32%299.85M | 99.64%-2.68M | 169.45%351.16M | -211.06%-113.94M | -157.83%-584.27M | -175.48%-739.71M | -200.75%-505.6M |
| Add:Begin period cash and cash equivalents | 13.91%2.46B | 13.91%2.46B | 13.91%2.46B | -21.32%2.16B | -21.32%2.16B | -21.32%2.16B | -21.32%2.16B | 58.39%2.74B | 58.39%2.74B | 58.39%2.74B |
| End period cash equivalent | 0.60%2.17B | -7.94%2.31B | -3.56%1.97B | 13.91%2.46B | 7.64%2.15B | 12.19%2.51B | -28.17%2.04B | -21.32%2.16B | -26.18%2B | 0.13%2.23B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.